Literature DB >> 2847080

Neuromuscular effects distant from the site of botulinum neurotoxin injection.

R K Olney1, M J Aminoff, D J Gelb, D H Lowenstein.   

Abstract

We assessed the severity and temporal profile of distant neuromuscular effects from a single dose (280 units) of botulinum neurotoxin injected into neck muscles for torticollis. We performed single-fiber EMG studies on the biceps brachii of six patients to measure jitter (20 pairs) and fiber density on the initial treatment day and then again, at least once more, after 2 to 12 weeks. No patient developed weakness beyond the neck muscles or decrement of the biceps response to repetitive 3-Hz nerve stimulation. Between the baseline and the last follow-up study, the average of mean MCD increased from 29 microseconds to 38 microseconds (31%). Mean fiber density increased concurrently or earlier from 1.35 to 1.79 (33%). There were no electrophysiologic signs of presynaptic blockade, even at 2 and 4 weeks. The effects we observed are compatible with stimulation of terminal sprouting by the neurotoxin, without significant presynaptic inhibition of acetylcholine release. We therefore believe that higher dosages of the neurotoxin may be used if clinically indicated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847080     DOI: 10.1212/wnl.38.11.1780

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.

Authors:  W Poewe; L Schelosky; B Kleedorfer; F Heinen; M Wagner; G Deuschl
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

Review 2.  Neurophysiological effects of botulinum toxin type A.

Authors:  G Abbruzzese; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

4.  Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.

Authors:  A M Bakheit; C D Ward; D L McLellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

5.  Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A.

Authors:  D Tiple; S Strano; C Colosimo; G Fabbrini; G Calcagnini; M Prencipe; A Berardelli
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

6.  Influence of injection of Chinese botulinum toxin type A on the histomorphology and myosin heavy chain composition of rat gastrocnemius muscles.

Authors:  Bin Hong; Min Chen; Xing-yue Hu
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

7.  Safety aspects of incobotulinumtoxinA high-dose therapy.

Authors:  Dirk Dressler; Fereshte Adib Saberi; Katja Kollewe; Christoph Schrader
Journal:  J Neural Transm (Vienna)       Date:  2014-07-17       Impact factor: 3.575

8.  Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.

Authors:  P Girlanda; G Vita; C Nicolosi; S Milone; C Messina
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

9.  Clinical and electrophysiological studies of botulinum toxin type A to treat hemifacial spasm complicated with auricular symptoms.

Authors:  Bin Peng; Hongjuan Dong; Hong Chu; Shenqi Zhang; Zuneng Lu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Botulinum toxin treatment of spasmodic torticollis.

Authors:  T J Anderson; J Rivest; R Stell; M J Steiger; H Cohen; P D Thompson; C D Marsden
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.